Leucine and Protein Metabolism in Obese Zucker Rats

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  She, Pengxiang ^a   Olson, Kristine C ^a   Kadota, Yoshihiro ^b   Inukai, Ayami ^b   Shimomura, Yoshiharu ^b   Hoppel, Charles L ^c   Adams, Sean H ^d   Kawamata, Yasuko ^e   Matsumoto, Hideki ^e   Sakai, Ryosei ^e   Lang, Charles H ^a   Lynch, Christopher J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NAGOYA UNIVERSITY   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLHISTIDINE; ACYLCARNITINE; BRANCHED CHAIN AMINO ACID; BRANCHED CHAIN KETO ACID DEHYDROGENASE COMPLEX; CARNITINE; CREATININE; GLUCOSE; HYDROXYPROLINE; INSULIN; LEUCINE; OXIDOREDUCTASE; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CATABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; HEART; INSULIN BLOOD LEVEL; KIDNEY; LEAN BODY WEIGHT; LIPID COMPOSITION; LIVER WEIGHT; MALE; METABOLOMICS; MUSCLE MASS; NONHUMAN; OBESITY; OXIDATION; PATHOPHYSIOLOGY; PLANTARIS MUSCLE; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RAT; TISSUE SPECIFICITY; URINE LEVEL; WEIGHT GAIN;

3-METHYL-2-OXOBUTANOATE DEHYDROGENASE (LIPOAMIDE); ADIPOSE TISSUE; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CARBON RADIOISOTOPES; CARNITINE; CHROMATOGRAPHY, LIQUID; CREATININE; LEUCINE; LIVER; MALE; METABOLOMICS; MUSCLE, SKELETAL; OBESITY; ORGAN SIZE; PROTEINS; RATS; RATS, ZUCKER; TANDEM MASS SPECTROMETRY;

EID: 84875159157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059443     Document Type: Article

References (94)

1. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, et al. (2006) Hypothalamic mTOR signaling regulates food intake. Science 312: 927-930.
2. Su Y, Lam TK, He W, Pocai A, Bryan J, et al. (2012) Hypothalamic leucine metabolism regulates liver glucose production. Diabetes 61: 85-93.
3. Zhou Y, Jetton TL, Goshorn S, Lynch CJ, She P (2010) Transamination Is Required for {alpha}-Ketoisocaproate but not Leucine to Stimulate Insulin Secretion. J Biol Chem.
4. Lynch CJ, Patson BJ, Anthony J, Vaval A, Jefferson LS, et al. (2002) Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol Endocrinol Metab 283: E503-513.
5. Lynch CJ, Gern B, Lloyd C, Hutson SM, Eicher R, et al. (2006) Leucine in food mediates some of the postprandial rise in plasma leptin concentrations. American journal of physiology Endocrinology and metabolism 291: E621-630.
6. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, et al. (2002) Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 299: 693-696.
7. Adibi SA, (1968) Influence of dietary deprivations on plasma concentration of free amino acids of man. J Appl Physiol 25: 52-57.
8. Felig P, Marliss E, Cahill GF Jr, (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281: 811-816.
9. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
10. Um SH, D'Alessio D, Thomas G, (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3: 393-402.
11. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453.
12. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, et al. (2011) Dietary leucine-an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 6: e21187.
13. Adams SH, (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Advances in nutrition 2: 445-456.
14. Welle S, Barnard RR, Statt M, Amatruda JM, (1992) Increased protein turnover in obese women. Metabolism 41: 1028-1034.
15. Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB, et al. (2006) The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55: 675-681.
16. Bruce AC, McNurlan MA, McHardy KC, Broom J, Buchanan KD, et al. (1990) Nutrient oxidation patterns and protein metabolism in lean and obese subjects. Int J Obes 14: 631-646.
17. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D, (1983) Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25: 400-403.
18. Welle S, Nair KS, (1990) Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 258: E990-998.
19. Jensen MD, Haymond MW, (1991) Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr 53: 172-176.
20. Nair KS, Halliday D, Ford GC, Heels S, Garrow JS, (1987) Failure of carbohydrate to spare leucine oxidation in obese subjects. International journal of obesity 11: 537-544.
21. Marchesini G, Bianchi G, Rossi B, Muggeo M, Bonora E, (2000) Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance. Int J Obes Relat Metab Disord 24: 552-558.
22. Jin L, Ge S, Wang H, Gao X, Jin J, et al. (2012) Metabolic Effects of Intraoperative Amino Acid Infusion in Mongrel Dogs. Annals of Nutrition & Metabolism 61: 117-125.
23. Vary TC, Lynch CJ, (2007) Nutrient signaling components controlling protein synthesis in striated muscle. The Journal of nutrition 137: 1835-1843.
24. Chan CP, Hansen RJ, Stern JS, (1985) Protein turnover in insulin-treated, alloxan-diabetic lean and obese Zucker rats. The Journal of nutrition 115: 959-969.
25. Argiles JM, (1989) The obese Zucker rat: a choice for fat metabolism 1968-1988: twenty years of research on the insights of the Zucker mutation. Progress in lipid research 28: 53-66.
26. Argiles JM, Busquets S, Alvarez B, Lopez-Soriano FJ, (1999) Mechanism for the increased skeletal muscle protein degradation in the obese zucker rat. The Journal of nutritional biochemistry 10: 244-248.
27. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE, (2010) Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Molecular bioSystems 6: 909-921.
28. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, et al. (2010) Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5: e15234.
29. Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, et al. (2009) Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One 4: e7905.
30. Pietilainen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, et al. (2008) Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 5: e51.
31. Deo RC, Hunter L, Lewis GD, Pare G, Vasan RS, et al. (2010) Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput Biol 6: e1000692.
32. Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB, (2010) Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 285: 11348-11356.
33. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, et al. (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. American journal of physiology Endocrinology and metabolism 293: E1552-1563.
34. Bajotto G, Murakami T, Nagasaki M, Sato Y, Shimomura Y, (2009) Decreased enzyme activity and contents of hepatic branched-chain alpha-keto acid dehydrogenase complex subunits in a rat model for type 2 diabetes mellitus. Metabolism 58: 1489-1495.
35. Doisaki M, Katano Y, Nakano I, Hirooka Y, Itoh A, et al. (2010) Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun 393: 303-307.
36. Kuzuya T, Katano Y, Nakano I, Hirooka Y, Itoh A, et al. (2008) Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun 373: 94-98.
37. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, et al. (1998) A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68: 72-81.
38. Brosnan JT, Brosnan ME, (2006) Branched-chain amino acids: enzyme and substrate regulation. The Journal of nutrition 136: 207S-211S.
39. Attie AD, Scherer PE, (2009) Adipocyte metabolism and obesity. J Lipid Res 50 (Suppl):: S395-399.
40. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, et al. (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431: 200-205.
41. Allsop JR, Wolfe RR, Burke JF, (1978) Tracer priming the bicarbonate pool. J Appl Physiol 45: 137-139.
42. Wolfe RR, Chinkes DL (2005) Whole body protein synthesis and breakdown. Isotope tracers in metabolic research. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc. 299-323.
43. Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, et al. (2012) Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7: e38812.
44. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, et al. (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32: 1678-1683.
45. Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, et al. (2010) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Molecular Psychiatry 16: 569-581.
46. Wilson GJ, Layman DK, Moulton CJ, Norton LE, Anthony TG, et al. (2011) Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats. Am J Physiol Endocrinol Metab 301: E1236-1242.
47. Aranibar N, Vassallo JD, Rathmacher J, Stryker S, Zhang Y, et al. (2011) Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling. Analytical biochemistry 410: 84-91.
48. Hutson SM, Cree TC, Harper AE, (1978) Regulation of leucine and alpha-ketoisocaproate metabolism in skeletal muscle. The Journal of biological chemistry 253: 8126-8133.
49. Lynch CJ, Zhou Q, Shyng SL, Heal DJ, Cheetham SC, et al. (2012) Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. American journal of physiology Endocrinology and metabolism 302: E540-551.
50. Kand'ar R, Zakova P, Jirosova J, Sladka M, (2009) Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection. Clin Chem Lab Med 47: 565-572.
51. Hutson SM, Harper AE, (1981) Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease. Am J Clin Nutr 34: 173-183.
52. Minkler PE, Ingalls ST, Hoppel CL, (2005) Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitines. Analytical chemistry 77: 1448-1457.
53. Minkler PE, Stoll MS, Ingalls ST, Yang S, Kerner J, et al. (2008) Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry. Clinical chemistry 54: 1451-1462.
54. Schwenk WF, Beaufrere B, Haymond MW, (1985) Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol 249: E646-650.
55. Vazquez JA, Paul HS, Adibi SA, (1986) Relation between plasma and tissue parameters of leucine metabolism in fed and starved rats. Am J Physiol 250: E615-621.
56. Nakai N, Kobayashi R, Popov KM, Harris RA, Shimomura Y, (2000) Determination of branched-chain alpha-keto acid dehydrogenase activity state and branched-chain alpha-keto acid dehydrogenase kinase activity and protein in mammalian tissues. Methods in enzymology 324: 48-62.
57. Matsumoto H, Akita K, Sakai R, Shimomura Y, (2010) Analysis of branched-chain alpha-keto acid dehydrogenase complex activity in rat tissues using alpha-keto[1-13C]isocaproate as substrate. Analytical biochemistry 399: 1-6.
58. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289-300.
59. Zucker LM, (1972) Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty". Journal of lipid research 13: 234-243.
60. Albaugh VL, Vary TC, Ilkayeva O, Wenner BR, Maresca KP, et al. (2012) Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophrenia bulletin 38: 153-166.
61. Vary TC, Lynch CJ, (2006) Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation. American journal of physiology Endocrinology and metabolism 290: E631-642.
62. Luzi L, Castellino P, DeFronzo RA, (1996) Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 270: E273-281.
63. Bornstein P, (1974) The biosynthesis of collagen. Annual review of biochemistry 43: 567-603.
64. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, et al. (2009) Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. The Journal of nutrition 139: 1073-1081.
65. Yang S, Minkler P, Hoppel C, (2007) cis-3,4-Methylene-heptanoylcarnitine: characterization and verification of the C8:1 acylcarnitine in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 857: 251-258.
66. Lynch CJ, Hutson SM, Patson BJ, Vaval A, Vary TC, (2002) Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats. American journal of physiology Endocrinology and metabolism 283: E824-835.
67. Harris RA, Powell SM, Paxton R, Gillim SE, Nagae H, (1985) Physiological covalent regulation of rat liver branched-chain alpha-ketoacid dehydrogenase. Archives of biochemistry and biophysics 243: 542-555.
68. Lu G, Sun H, She P, Youn JY, Warburton S, et al. (2009) Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. The Journal of clinical investigation 119: 1678-1687.
69. Sun H, Lu G, Ren S, Chen J, Wang Y, (2011) Catabolism of branched-chain amino acids in heart failure: insights from genetic models. Pediatric cardiology 32: 305-310.
70. Oyarzabal A, Martinez-Pardo M, Merinero B, Navarrete R, Desviat LR, et al. (2012) A Novel Regulatory Defect in the Branched-Chain Alpha-Ketoacid Dehydrogenase Complex Due to a Mutation in the PPM1K Gene Causes a Mild Variant Phenotype of Maple Syrup Urine Disease. Human mutation.
71. Fluckey JD, Cortright RN, Tapscott E, Koves T, Smith L, et al. (2004) Active involvement of PKC for insulin-mediated rates of muscle protein synthesis in Zucker rats. American journal of physiology Endocrinology and metabolism 286: E753-758.
72. Vary TC, Goodman S, Kilpatrick LE, Lynch CJ, (2005) Nutrient regulation of PKCepsilon is mediated by leucine, not insulin, in skeletal muscle. American journal of physiology Endocrinology and metabolism 289: E684-694.
73. Bohe J, Low JF, Wolfe RR, Rennie MJ, (2001) Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. The Journal of physiology 532: 575-579.
74. Norton LE, Layman DK, Bunpo P, Anthony TG, Brana DV, et al. (2009) The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats. The Journal of nutrition 139: 1103-1109.
75. Torres TP, Catlin RL, Chan R, Fujimoto Y, Sasaki N, et al. (2009) Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. Diabetes 58: 78-86.
76. Jin ES, Park BH, Sherry AD, Malloy CR, (2007) Role of excess glycogenolysis in fasting hyperglycemia among pre-diabetic and diabetic Zucker (fa/fa) rats. Diabetes 56: 777-785.
77. Buque X, Martinez MJ, Cano A, Miquilena-Colina ME, Garcia-Monzon C, et al. (2010) A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. Journal of lipid research 51: 500-513.
78. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, et al. (2007) Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 6: 181-194.
79. Murakami DM, Horwitz BA, Fuller CA, (1995) Circadian rhythms of temperature and activity in obese and lean Zucker rats. The American journal of physiology 269: R1038-1043.
80. Goldberg JR, Ehrmann B, Katzeff HL, (1988) Altered triiodothyronine metabolism in Zucker fatty rats. Endocrinology 122: 689-693.
81. Durbin-Naltchayan S, Bouhnik J, Michel R, (1983) Thyroid status in the obese syndrome of rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 15: 547-549.
82. Palaiologos G, Felig P, (1976) Effects of ketone bodies on amino acid metabolism in isolated rat diaphragm. The Biochemical journal 154: 709-716.
83. Felig P, (1973) The glucose-alanine cycle. Metabolism: clinical and experimental 22: 179-207.
84. Ruderman NB, Berger M, (1974) The formation of glutamine and alanine in skeletal muscle. The Journal of biological chemistry 249: 5500-5506.
85. Felig P, Wahren J, (1971) Amino acid metabolism in exercising man. The Journal of clinical investigation 50: 2703-2714.
86. Zelezniak A, Pers TH, Soares S, Patti ME, Patil KR, (2010) Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS computational biology 6: e1000729.
87. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56.
88. De Vogel-van den Bosch J, Hoeks J, Timmers S, Houten SM, van Dijk PJ, et al. (2011) The effects of long- or medium-chain fat diets on glucose tolerance and myocellular content of lipid intermediates in rats. Obesity 19: 792-799.
89. Bosma M, Kersten S, Hesselink MK, Schrauwen P, (2012) Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Progress in lipid research 51: 36-49.
90. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18: 1695-1700.
91. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, et al. (2010) alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5: e10883.
92. Litvak J, Wortsman J, Pumarino H, Armendaris R, (1968) Effect of fasting on urinary calcium and hydroxyproline excretion in obesity. The Journal of clinical endocrinology and metabolism 28: 311-312.
93. Brown H, Milner A, Kennedy J, Delena S, (1968) Hydroxyproline excretion during starvation of obese subjects. Metabolism: clinical and experimental 17: 345-351.
94. Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, et al. (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11: 1919-1932.